BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25327490)

  • 21. Circulating miRNAs as Biomarker in Cancer.
    Andersen GB; Tost J
    Recent Results Cancer Res; 2020; 215():277-298. PubMed ID: 31605235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNAs: Promising biomarkers for cancer diagnosis and prognosis.
    Wei G; Zhu J; Hu HB; Liu JQ
    Gene; 2021 Mar; 771():145365. PubMed ID: 33346098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis.
    Muthamilselvan S; Ramasami Sundhar Baabu P; Palaniappan A
    Technol Cancer Res Treat; 2023; 22():15330338231185284. PubMed ID: 37365928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-coding RNAs for medical practice in oncology.
    Setoyama T; Ling H; Natsugoe S; Calin GA
    Keio J Med; 2011; 60(4):106-13. PubMed ID: 22200634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNAs as Promising Tumor Biomarkers.
    Chen M; Calin GA; Meng QH
    Adv Clin Chem; 2014; 67():189-214. PubMed ID: 25735862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers.
    Yang Z; Xie L; Han L; Qu X; Yang Y; Zhang Y; He Z; Wang Y; Li J
    Theranostics; 2017; 7(12):3106-3117. PubMed ID: 28839467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CircRNA: functions and properties of a novel potential biomarker for cancer.
    Meng S; Zhou H; Feng Z; Xu Z; Tang Y; Li P; Wu M
    Mol Cancer; 2017 May; 16(1):94. PubMed ID: 28535767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coding RNAs: the cancer genome dark matter that matters!
    Ling H; Girnita L; Buda O; Calin GA
    Clin Chem Lab Med; 2017 May; 55(5):705-714. PubMed ID: 27988500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
    de Gonzalo-Calvo D; Vea A; Bär C; Fiedler J; Couch LS; Brotons C; Llorente-Cortes V; Thum T
    Eur Heart J; 2019 May; 40(20):1643-1650. PubMed ID: 29688487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-coding RNAs including miRNAs, piRNAs, and tRNAs in human cancer.
    Heyns M; Kovalchuk O
    Oncotarget; 2015 Sep; 6(27):23055-7. PubMed ID: 26405161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
    Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
    Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
    Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
    Qin C; Huang RY; Wang ZX
    Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs and cancer: a meeting summary of the eponymous Keystone Conference.
    Godshalk SE; Melnik-Martinez KV; Pasquinelli AE; Slack FJ
    Epigenetics; 2010 Feb; 5(2):164-8. PubMed ID: 20168081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of circulating non-coding RNAs - an update.
    Anfossi S; Babayan A; Pantel K; Calin GA
    Nat Rev Clin Oncol; 2018 Sep; 15(9):541-563. PubMed ID: 29784926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.